Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Treatable Neurological Disorders Misdiagnosed as Creutzfeldt-Jakob Disease
Ann Neurol 70:437-444, Chitravas, N.,et al, 2011
Carbamazepine Encephalopathy Masquerading as Creutzfeldt-Jakob Disease
Neurol 65:650-651, Horvath,J.,et al, 2005
Sensitivity of 14-3-3 Protein Test Varies in Subtypes of Sporadic Creutzfeldt-Jakob Disease
Neurol 63:436-442,410, Castellani,R.J.,et al, 2004
CJD--A Case of Mistaken Identity
Lancet 364:2068, Campbell,S.,et al, 2004
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Arch Neurol 60:813-816,803, Geschwind,M.D.,et al, 2003
14-3-3 Protein in the CSF of Patients with Rapidly Progressive Dementia
Neurol 61:354-357, Huang,N.,et al, 2003
CSF Detection of the 14-3-3 Protein in Unselected Patients with Dementia
Neurol 56:1528-1533, Burkhard,P.R.,et al, 2001
14-3-3 Testing in Diagnosing Creutzfeldt-Jakob Disease
Neurol 55:514-516, Lemstra,A.W. et al, 2000
Misleading Results With the 14-3-3 Assay for the Diagnosis of Creutzfeldt-Jakob Disease
Neurol 55:1396-1397, Chapman,T.,et al, 2000